Etonogestrel implant
ایمپلنت اتونوژسترل
🚻 Genito Urinary System And Sex HormonesProgestin (long-acting contraceptive)
Market / country: 🇺🇸 USA
Nexplanon (US)
🧮 Dose calculator
Contraception (combined pill) · Regimen source: FDA Nexplanon · 1FDA Nexplanon · 2
- • Rule out pregnancy before insertion; timing depends on prior contraception. Insertion and removal only by trained providers (REMS). FDA Nexplanon · 2.1FDA Nexplanon · 2.2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Known or suspected pregnancy; current or past thrombosis; liver tumours or active liver disease; undiagnosed abnormal uterine bleeding; current or past breast or other progestin-sensitive cancer; allergy to components. FDA Nexplanon · 4
Warnings
- • Boxed warning: complications of improper insertion and removal (nerve/vascular injury, migration, including to pulmonary vessels). FDA Nexplanon · Boxed Warning
- • Changed bleeding pattern; ectopic pregnancy; thrombosis; ovarian cysts; raised blood pressure; reduced efficacy with CYP3A4 inducers. FDA Nexplanon · 5
Formulations
- One 68 mg etonogestrel rod in a preloaded applicator — subdermal implant 🇺🇸 USA FDA Nexplanon · 3
👥 Special populations
- 🤰 PregnancyContraindicated
Label: contraindicated in pregnancy. FDA Nexplanon · 4
“NEXPLANON should not be used in women who have Known or suspected pregnancy Current or past history of thrombosis or thromboembolic disorders Liver tumors, benign or malignant, or active liver disease Undiagnosed abnormal uterine bleeding Known or suspected breast cancer, personal history of breast cancer, or other …”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Nexplanon · 8.2
“Risk Summary Small amounts of contraceptive steroids and/or metabolites, including etonogestrel are present in human milk.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Nexplanon · 8.4
“The safety and effectiveness of NEXPLANON have been established in women of reproductive potential.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Nexplanon · 8.5
“This product has not been studied in women over 65 years of age and is not indicated in this population.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA021529
- DailyMed (FDA label)FDA Nexplanon
- MedlinePlus (NIH)Etonogestrel Implant
- WHO ATC/DDDG03AC08
- Darooyab (Iran)Etonogestrel
🇮🇷 Not found in Iran list Darooyab · G-3260/Etonogestrel
Darooyab lists no registered dosage form or brand for this drug. This does not prove it is unavailable.
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Nexplanon · 3FDA Nexplanon · 1FDA Nexplanon · 2FDA Nexplanon · 2.1FDA Nexplanon · 2.2FDA Nexplanon · 4FDA Nexplanon · Boxed WarningFDA Nexplanon · 5FDA Nexplanon · 8.2FDA Nexplanon · 8.4FDA Nexplanon · 8.5FDA Nexplanon · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-3260/Etonogestrel
- Clinical review⚠ Unverified